FLT3 and neoplasm: It is a multi-kinase inhibitor of tumor growth and angiogenesis, which can significantly inhibit C and B-Raf serine/ threonine kinases, vascular endothelial growth factor receptor, platelet-derived growth factor receptor, tyrosine kinases and FLT-3 (fms related tyrosine kinase 3) [12–14].